219750 — BTB Korea Co Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for BTB Korea Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS/A | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,124 | 7,199 | 56.1 | 562 | 18,059 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6,155 | 8,378 | 2,522 | 1,502 | 2,004 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 19,671 | 26,327 | 11,450 | 5,141 | 21,799 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 15,381 | 19,292 | 18,374 | 15,988 | 15,447 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 40,400 | 51,027 | 44,973 | 35,078 | 37,532 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 17,305 | 29,222 | 25,915 | 31,064 | 36,529 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 25,852 | 40,767 | 33,675 | 31,912 | 37,123 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 14,548 | 10,260 | 11,298 | 3,166 | 409 |
Total Liabilities & Shareholders' Equity | 40,400 | 51,027 | 44,973 | 35,078 | 37,532 |
Total Common Shares Outstanding |